Using information in medical records for more than 1,100 emergency room visits, researchers at Johns Hopkins Children's ...

Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer and personalized.

Community rallies to save beloved feline, surplus funds to aid other animals in need.

Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive ...

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

The ADAPT trial involves 70 refractory glaucoma patients, focusing on a 12-month primary effectiveness endpoint to evaluate the Calibreye TGT Surgical System. The Calibreye system is the first ...

For two days, the patient lived as a human being with no lungs, stabilized by a machine that breathed and buffered his ...

Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive ...

The pharmaceutical company is running investigational new drug experiments, studies required by the FDA to demonstrate the ...

Myra Vision, a Shifamed portfolio company, today announced the first patient enrolled in its ADAPT clinical study evaluating ...

FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be ...